1,734
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Alkannin restrains oral squamous carcinoma cell growth, migration and invasion by regulating microRNA-9/RECK axis

, , &
Pages 3153-3162 | Received 25 Feb 2019, Accepted 03 Jul 2019, Published online: 26 Jul 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (7)

Fangyuan Qi, Yaru Wang, Bingxin Yu & Fan Li. (2023) Identification of RECK as a protective prognostic indicator and a tumor suppressor through regulation of the ERK/MAPK signaling pathway in gastric cancer. Journal of Translational Medicine 21:1.
Crossref
Zhong‐Zhao Zhang, Chang‐Hui Wen, Min Jia, Hong‐Qiang Zhang & Shao‐Qin Sun. (2022) Alkannin exerts antitumor properties in cutaneous squamous cell carcinoma by inducing apoptosis and shifting the M1 / M2 polarization of tumor‐associated macrophages by upregulating PTEN . The Kaohsiung Journal of Medical Sciences 39:1, pages 70-79.
Crossref
Mingjing Jiang & Bo Li. (2022) STAT3 and Its Targeting Inhibitors in Oral Squamous Cell Carcinoma. Cells 11:19, pages 3131.
Crossref
Elina Khatoon, Mangala Hegde, Aviral Kumar, Uzini Devi Daimary, Gautam Sethi, Anupam Bishayee & Ajaikumar B. Kunnumakkara. (2022) The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer. Archives of Pharmacal Research 45:8, pages 507-534.
Crossref
Shuntao Sun, Shanshan Zhao, Hongyu Yang & Feng Wang. (2022) microRNA 21 Promotes the Proliferation and Metastasis of Oral Squamous Cell Carcinoma by Targeting RECK. Journal of Hard Tissue Biology 31:4, pages 257-262.
Crossref
Yaowen Wang, Jingfang Zhang, Feipeng Wang, Wenping Chen, Jie Ma & Honggang Wang. (2021) Alkannin Inhibits the Development of Ovarian Cancer by Affecting miR-4461. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-8.
Crossref
Guochang Zhang, Nan Zhai & Xiaofen Zhang. (2020) Retracted: Alkannin represses growth of pancreatic cancer cells based on the down regulation of miR‐199a . BioFactors 46:5, pages 849-859.
Crossref